Prospective Trial of Water Vapor Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia in Subjects with a Large Prostate: 6- and 12-month Outcomes.

ABSTRACT:

Background

Current guidelines recommend Rezūm water vapor thermal therapy for the treatment of benign prostatic hyperplasia (BPH) for prostate glands ranging in volume from 30 to 80 cm³. Few prospective studies have specifically evaluated the use of Rezūm for larger prostates.

Objective

To evaluate the safety and efficacy of water vapor thermal therapy in patients with a prostate gland >80 cm³ and ≤150 cm³.

Design setting and participants

In this prospective, single-arm study at seven centers in the USA, subjects were males aged >50 yr with symptomatic BPH and prostate volume of >80 cm³ and ≤150 cm³.

Intervention

Rezūm was used to deliver sterile water vapor via a transurethral approach to ablate targeted a

SUBMITTER: Woo H 

PROVIDER: S-EPMC10751540 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature